News & Events

Domenick Bertelli Moderates Panel at MIT Sloan Healthcare and BioInnovations Conference on Gene and Cell Therapy and Next Generation Therapeutics

March 9, 2018
|
Conference Events

Domenick recently moderated a panel discussion exploring commercialization challenges for new precision medicine therapeutics on the frontiers of medicine. Focusing on Gene therapies, cell therapies, and tissue therapies, the panel discussed the emerging landscape:

  • A range of recently approved and soon-to-be-approved new treatments
  • Clinical trial design and recruitment
  • Pricing & reimbursement challenges and decision-making
  • The role of next-generation sequencing and other new diagnostics
  • How “big data” had contributed to breakthroughs

Panelists included:

Gray Chynoweth, Chief Membership Officer, ARMI
Zach Taylor, Director of Business Development & Strategy, Neon Therapeutics
Nevin Summers, Executive Director and Research Scientist-Architect at MIT Synthetic Biology Center
Jeremy Duffield, Associate Professor, University of Washington
Lee Steingisser, Vice President of Medical Innovation & Leadership, Blue Cross and Blue Shields of Massachusetts

The MIT Sloan Healthcare and BioInnovations Conference brings together industry, academic and policy leaders to discuss the most pressing issues and exciting innovations in the healthcare sector. The theme of this year’s conference was “Pathways to Innovation in Healthcare”.  Putnam was proud to once again be a sponsor and co-organizer of the SHBC conference.

Strategy for the Life Sciences